+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antinuclear Antibody Test Market 2024-2028

  • PDF Icon

    Report

  • 139 Pages
  • June 2024
  • Region: Global
  • TechNavio
  • ID: 5563174
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antinuclear antibody test market is forecasted to grow by USD 392 million during 2023-2028, accelerating at a CAGR of 7.08% during the forecast period. The report on the antinuclear antibody test market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for ana tests, rising government initiatives, and rising number of reagent rental agreements.

The antinuclear antibody test market is segmented as below:

By End-user

  • Hospitals
  • Clinical diagnostic laboratories

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing prevalence of autoimmune diseases as one of the prime reasons driving the antinuclear antibody test market growth during the next few years. Also, rising population and healthcare expenditure and increasing geriatric population will lead to sizable demand in the market.

The report on the antinuclear antibody test market covers the following areas:

  • Antinuclear antibody test market sizing
  • Antinuclear antibody test market forecast
  • Antinuclear antibody test market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antinuclear antibody test market vendors that include Abbott Laboratories, Abcam plc, Antibodies Inc., Bio Rad Laboratories Inc., BioVision Inc., Grifols SA, Immuno Concepts Ltd., Merck KGaA, Orgentec Diagnostika GmbH, Perkin Elmer Inc., Quidelortho Corp., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., Trinity Biotech Plc, Werfenlife SA, and ZEUS Scientific Inc. Also, the antinuclear antibody test market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Antinuclear Antibody Test Market 2018 - 2022
Historic Market Size - Data Table on Global Antinuclear Antibody Test Market 2018 - 2022 ($ million)
4.2 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Clinical diagnostic laboratories - Market size and forecast 2023-2028
Chart on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Data Table on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Chart on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Data Table on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
8.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity by geography
Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
11.4 Antibodies Inc.
Antibodies Inc. - Overview
Antibodies Inc. - Product / Service
Antibodies Inc. - Key offerings
11.5 BioVision Inc.
BioVision Inc. - Overview
BioVision Inc. - Product / Service
BioVision Inc. - Key offerings
11.6 Grifols SA
Grifols SA - Overview
Grifols SA - Business segments
Grifols SA - Key news
Grifols SA - Key offerings
Grifols SA - Segment focus
11.7 Immuno Concepts Ltd.
Immuno Concepts Ltd. - Overview
Immuno Concepts Ltd. - Product / Service
Immuno Concepts Ltd. - Key offerings
11.8 Orgentec Diagnostika GmbH
Orgentec Diagnostika GmbH - Overview
Orgentec Diagnostika GmbH - Product / Service
Orgentec Diagnostika GmbH - Key offerings
11.9 Perkin Elmer Inc.
Perkin Elmer Inc. - Overview
Perkin Elmer Inc. - Business segments
Perkin Elmer Inc. - Key news
Perkin Elmer Inc. - Key offerings
Perkin Elmer Inc. - Segment focus
11.10 Quidelortho Corp.
Quidelortho Corp. - Overview
Quidelortho Corp. - Product / Service
Quidelortho Corp. - Key news
Quidelortho Corp. - Key offerings
11.11 Werfenlife SA
Werfenlife SA - Overview
Werfenlife SA - Product / Service
Werfenlife SA - Key offerings
11.12 ZEUS Scientific Inc.
ZEUS Scientific Inc. - Overview
ZEUS Scientific Inc. - Product / Service
ZEUS Scientific Inc. - Key offerings
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Antinuclear Antibody Test Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on End-user - Market share 2023-2028 (%)
Exhibits 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by End-user ($ million)
Exhibits 43: Data Table on Market opportunity by End-user ($ million)
Exhibits 44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 45: Chart on Market share by geography 2023-2028 (%)
Exhibits 46: Data Table on Market share by geography 2023-2028 (%)
Exhibits 47: Chart on Geographic comparison
Exhibits 48: Data Table on Geographic comparison
Exhibits 49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 85: Market opportunity by geography ($ million)
Exhibits 86: Data Tables on Market opportunity by geography ($ million)
Exhibits 87: Impact of drivers and challenges in 2023 and 2028
Exhibits 88: Overview on criticality of inputs and factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Companies covered
Exhibits 92: Matrix on companies position and classification
Exhibits 93: Abbott Laboratories - Overview
Exhibits 94: Abbott Laboratories - Business segments
Exhibits 95: Abbott Laboratories - Key news
Exhibits 96: Abbott Laboratories - Key offerings
Exhibits 97: Abbott Laboratories - Segment focus
Exhibits 98: Antibodies Inc. - Overview
Exhibits 99: Antibodies Inc. - Product / Service
Exhibits 100: Antibodies Inc. - Key offerings
Exhibits 101: BioVision Inc. - Overview
Exhibits 102: BioVision Inc. - Product / Service
Exhibits 103: BioVision Inc. - Key offerings
Exhibits 104: Grifols SA - Overview
Exhibits 105: Grifols SA - Business segments
Exhibits 106: Grifols SA - Key news
Exhibits 107: Grifols SA - Key offerings
Exhibits 108: Grifols SA - Segment focus
Exhibits 109: Immuno Concepts Ltd. - Overview
Exhibits 110: Immuno Concepts Ltd. - Product / Service
Exhibits 111: Immuno Concepts Ltd. - Key offerings
Exhibits 112: Orgentec Diagnostika GmbH - Overview
Exhibits 113: Orgentec Diagnostika GmbH - Product / Service
Exhibits 114: Orgentec Diagnostika GmbH - Key offerings
Exhibits 115: Perkin Elmer Inc. - Overview
Exhibits 116: Perkin Elmer Inc. - Business segments
Exhibits 117: Perkin Elmer Inc. - Key news
Exhibits 118: Perkin Elmer Inc. - Key offerings
Exhibits 119: Perkin Elmer Inc. - Segment focus
Exhibits 120: Quidelortho Corp. - Overview
Exhibits 121: Quidelortho Corp. - Product / Service
Exhibits 122: Quidelortho Corp. - Key news
Exhibits 123: Quidelortho Corp. - Key offerings
Exhibits 124: Werfenlife SA - Overview
Exhibits 125: Werfenlife SA - Product / Service
Exhibits 126: Werfenlife SA - Key offerings
Exhibits 127: ZEUS Scientific Inc. - Overview
Exhibits 128: ZEUS Scientific Inc. - Product / Service
Exhibits 129: ZEUS Scientific Inc. - Key offerings
Exhibits 130: Inclusions checklist
Exhibits 131: Exclusions checklist
Exhibits 132: Currency conversion rates for US$
Exhibits 133: Research methodology
Exhibits 134: Information sources
Exhibits 135: Data validation
Exhibits 136: Validation techniques employed for market sizing
Exhibits 137: Data synthesis
Exhibits 138: 360 degree market analysis
Exhibits 139: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global antinuclear antibody test market: Abbott Laboratories, Abcam plc, Antibodies Inc., Bio Rad Laboratories Inc., BioVision Inc., Grifols SA, Immuno Concepts Ltd., Merck KGaA, Orgentec Diagnostika GmbH, Perkin Elmer Inc., Quidelortho Corp., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., Trinity Biotech Plc, Werfenlife SA, and ZEUS Scientific Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing prevalence of autoimmune diseases."

According to the report, one of the major drivers for this market is the increasing demand for ana tests.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Abcam plc
  • Antibodies Inc.
  • Bio Rad Laboratories Inc.
  • BioVision Inc.
  • Grifols SA
  • Immuno Concepts Ltd.
  • Merck KGaA
  • Orgentec Diagnostika GmbH
  • Perkin Elmer Inc.
  • Quidelortho Corp.
  • Seramun Diagnostica GmbH
  • Thermo Fisher Scientific Inc.
  • Transasia Bio Medicals Ltd.
  • Trinity Biotech Plc
  • Werfenlife SA
  • ZEUS Scientific Inc.